Two Sigma Securities, LLC Biogen Inc. Transaction History

Two Sigma Securities, LLC

$5.78 Billion
Q3 2024

A detailed history of Two Sigma Securities, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 10,659 shares of BIIB stock, worth $1.59 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

10,659

Previous 12,800 16.73%

Holding current value

$1.59 Million

Previous $2.97 Million 30.37%

% of portfolio

0.04%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $2.02 Million - $2.52 Million	10,659 New	10,659 $2.07 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $636,060 - $803,129	3,000 New	3,000 $646,000
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $1.54 Million - $1.78 Million	-5,585 Reduced 80.95%	1,314 $374,000
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $1.48 Million - $1.68 Million	5,755 Added 503.06%	6,899 $1.92 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $322,113 - $391,374	-1,276 Reduced 52.73%	1,144 $316,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $471,149 - $649,673	2,420 New	2,420 $646,000
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $1.59 Million - $2 Million	8,184 Added 484.55%	9,873 $2.08 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $208,245 - $267,626	930 Added 122.53%	1,689 $405,000
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $95,479 - $111,859	-393 Reduced 34.11%	759 $212,000
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $684,208 - $1.03 Million	-2,896 Reduced 71.54%	1,152 $282,000
Q2 2020 Sep 10, 2020	SELL	$258.66 - $342.55 $6.13 Million - $8.12 Million	-23,700 Reduced 85.41%	4,048 $1.08 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $6.96 Million - $9.22 Million	26,920 Added 3251.21%	27,748 $7.42 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $1.79 Million - $2.48 Million	-8,152 Reduced 90.78%	828 $246,000
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $241,358 - $270,706	1,110 Added 14.1%	8,980 $2.09 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $1.13 Million - $1.24 Million	5,140 Added 188.28%	7,870 $1.84 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $428,002 - $669,446	1,975 Added 261.59%	2,730 $645,000
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $1.75 Million - $2.22 Million	-6,289 Reduced 89.28%	755 $227,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $1.8 Million - $2.35 Million	6,133 Added 673.22%	7,044 $2.49 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $744,490 - $887,276	-2,891 Reduced 76.04%	911 $264,000
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $989,014 - $1.4 Million	3,802 New	3,802 $1.04 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account

Two Sigma Securities, LLC Biogen Inc. Transaction History